NCT06527846View on ClinicalTrials.gov

Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Kidney Disease, Chronic
Interventions
DRUG

JARDIANCE®

JARDIANCE®

Trial Locations (1)

1416017

RECRUITING

Nippon Boehringer Ingelheim Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06527846 - Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter